SOPH
SOPHiA GENETICS SA · Technology · Market cap $474.6M(Price slightly stale)
Insiders sold $2.6M net in the last 90 days ·10 sellers, 0 buyers· 40 of 41 sales under Rule 10b5-1 plans· latest Form 4 filed Oct 14, 2026
Insider Buying
$99K
reported purchases (SEC code P)
Insider Selling
$5.2M
reported sales (SEC code S)
Unique Insiders
10
in the rolling window
Latest filing
Oct 14, 2026
Xu Zhenyu
SOPHiA GENETICS SA (SOPH) has 134 SEC Form 4 filings (181 transaction rows) in the rolling window, disclosed by 10 distinct insiders. Most recent filing: Oct 14, 2026.
Inside the rolling window, 10 insiders at SOPHiA GENETICS SA reported 1 open-market purchase totaling $99K and 136 open-market sales totaling $5.2M. The most active filer is Executive Chairman Camblong Jurgi with 28 filings. Insiders have net sold $4.2M over the trailing 6 months. The most recent open-market filing is a sale of 4,000 shares by Chief Scientific Officer Xu Zhenyu, dated Oct 13, 2026, worth $29K.
- Industry:Medical - Healthcare Information Services
- CEO:Ross Muken
- Employees:415
- HQ:Rolle, VD, CH
- IPO:2021-07-23
| Source | |||||||
|---|---|---|---|---|---|---|---|
| Chief Scientific Officer | Sale | 4,000 | $29K | Oct 14 | -1.8% | SEC ↗ | |
| Executive Chairman | Sale | 8,500 | $62K | Oct 14 | -1.8% | SEC ↗ | |
| Chief Medical Officer | Sale | 5,000 | $36K | Oct 14 | -1.8% | SEC ↗ | |
Puylaert KevinFirst in 3 months | Chief Sales Officer | Sale | 216 | $2K | Oct 7 | -3.1% | SEC ↗ |
| Chief Legal Officer | Sale | 6,168 | $50K | Oct 7 | -3.1% | SEC ↗ | |
| Chief Scientific Officer | Sale | 7,394 | $60K | Oct 7 | -3.1% | SEC ↗ | |
| Executive Chairman | Sale | 40,172 | $327K | Oct 7 | -3.1% | SEC ↗ | |
| Chief Financial Officer | Sale | 1,592 | $13K | Oct 7 | -3.1% | SEC ↗ | |
| Chief Executive Officer | Sale | 9,838 | $80K | Oct 7 | -3.1% | SEC ↗ | |
| Chief Technology Officer | Sale | 5,284 | $43K | Oct 7 | — | SEC ↗ | |
| Chief People Officer | Sale | 4,240 | $34K | Oct 7 | — | SEC ↗ | |
| Chief Medical Officer | Sale | 7,394 | $60K | Oct 7 | — | SEC ↗ | |
| Chief Financial Officer | Sale | 774 | $6K | Sep 22 | — | SEC ↗ | |
| Chief Executive Officer | Sale | 422 | $4K | Sep 22 | — | SEC ↗ | |
| Chief Medical Officer | Sale | 5,000 | $39K | Sep 16 | — | SEC ↗ | |
| Chief Scientific Officer | Sale | 4,000 | $32K | Sep 16 | — | SEC ↗ | |
| Executive Chairman | Sale | 8,500 | $65K | Sep 14 | — | SEC ↗ | |
Van Well DaanFirst in 4 months | Chief Legal Officer | Sale | 6,168 | $47K | Sep 14 | — | SEC ↗ |
| Director | Sale | 6,250 | $51K | Sep 10 | — | SEC ↗ | |
| Chief Scientific Officer | Sale | 10,000 | $89K | Aug 31 | — | SEC ↗ | |
| Chief Medical Officer | Sale | 5,000 | $43K | Aug 26 | — | SEC ↗ | |
HIBBS KATHY LFirst in 4 months | Director | Sale | 6,250 | $54K | Aug 26 | — | SEC ↗ |
| Chief Technology Officer | Sale | 5,000 | $41K | Aug 26 | — | SEC ↗ | |
| Chief Technology Officer | Sale | 5,000 | $44K | Aug 26 | — | SEC ↗ | |
| Chief Scientific Officer | Sale | 10,000 | $79K | Aug 21 | — | SEC ↗ |
Earnings: last 7 quarters
Frequently asked questions
How many SEC Form 4 insider filings does SOPH have?
SOPHiA GENETICS SA (SOPH) has 134 SEC Form 4 filings (181 transaction rows) in the rolling 365-day window, disclosed by 10 distinct insiders. Most recent filing: Oct 14, 2026.
When was the most recent SEC Form 4 filing for SOPH?
The most recent Form 4 filing for SOPH on Tracefour is dated Oct 14, 2026.
Who is the most active insider at SOPH?
The most active SEC Form 4 filer at SOPH in the rolling window is Executive Chairman Camblong Jurgi, with 28 filings.
What is the net insider flow at SOPH over the last 6 months?
Over the trailing 180 days, insiders at SOPH have net sold $4.2M based on SEC Form 4 disclosures.
What is the total insider buy and sell value at SOPH in the current window?
Inside the rolling window, insiders at SOPH bought $99K and sold $5.2M based on SEC Form 4 filings.
Can I get alerts for SOPH insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at SOPHiA GENETICS SA (SOPH). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
SOPHiA GENETICS SA is in the Technology sector.